procarbazine has been researched along with Hairy Cell Leukemia in 2 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoengen, A | 1 |
| Lawlor, E | 1 |
| O'Briain, DS | 1 |
| Finn, T | 1 |
| Ward, R | 1 |
| Rogers, FM | 1 |
| O'Brien, AA | 1 |
| Daly, PA | 1 |
2 other studies available for procarbazine and Hairy Cell Leukemia
| Article | Year |
|---|---|
[Chemotherapy of non-Hodgkin lymphomas].
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukemia, Hairy | 1980 |
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia.
Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic C | 1987 |